Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

February 2026

Lab Specimen Logistics Reach into the Home

Simple, at-home collection of blood samples could go a long way toward improving the patient experience while creating new opportunities for clinical laboratories. But it also presents unique logistical challenges as labs find themselves operating in a more consumer-centric landscape. That was one of the takeaways from “Taming the Specimen Logistics Beast,” a panel at […]

To access this post, you must purchase The Dark Report.

Lab Specimen Logistics Reach into the Home Read More »

Elizabeth Holmes Seeks Trump Clemency for Conviction

Elizabeth Holmes, the convicted former CEO of Theranos, is again drawing public attention as she seeks clemency from President Donald Trump, reviving interest in one of the most notorious fraud cases in Silicon Valley and clinical laboratory history. According to court filings with the US Department of Justice’s Office of the Pardon Attorney, Holmes has

To access this post, you must purchase The Dark Report.

Elizabeth Holmes Seeks Trump Clemency for Conviction Read More »

Office of Inspector General Briefs

Congress Wants Review of Test Fraud As part of a spending bill approved by Congress recently, there is a small provision that hints at future review of clinical laboratory tests by the US Department of Health and Human Services’ Office of Inspector General (OIG). Bill number H.R.7148 (Consolidated Appropriations Act of 2026) calls for the

To access this post, you must purchase The Dark Report.

Office of Inspector General Briefs Read More »

February 9, 2026, Intelligence: Late-Breaking Lab News

Texas Attorney General Ken Paxton filed a lawsuit against Epic Systems, intensifying scrutiny of how pediatric medical records are controlled and the broader power of dominant electronic health record (EHR) vendors. The suit alleges Epic unlawfully monopolizes the EHR market and uses deceptive practices to restrict parental access to minors’ health records, violating Texas law.

To access this post, you must purchase The Dark Report.

February 9, 2026, Intelligence: Late-Breaking Lab News Read More »

Director Blissfully Uninvolved with Finances of DP Rollout

One of the biggest aspects of a clinical laboratory switching from traditional glass slides to digital pathology is the potential cost of such a project. It’s difficult to provide a reliable range of how expensive digital pathology (DP) implementation is because of varying factors such as the size of the laboratory, specific scanners chosen, and

To access this post, you must purchase The Dark Report.

Director Blissfully Uninvolved with Finances of DP Rollout Read More »

PAMA Cuts Averted Until 2027; Labs Must Plan Next Move

Clinical laboratories have again avoided a potential financial disaster, at least for now, after Congress shifted PAMA cuts to test reimbursement rates until January 2027. However, the victory is temporary absent permanent PAMA reform. To that end, laboratory leaders need to push lawmakers to pass the RESULTS Act, with one healthcare attorney suggesting that labs

To access this post, you must purchase The Dark Report.

PAMA Cuts Averted Until 2027; Labs Must Plan Next Move Read More »

Permanent PAMA Reform Must Happen in 2026

Previously, it would have been hard to imagine even in the current political landscape that US immigration policy would somehow intersect with clinical laboratory test reimbursement. Yet, in recent weeks, that exact scenario happened as lawmakers reacted to a fatal shooting of a citizen protester by a federal agent in Minneapolis, during a crackdown on

To access this post, you must purchase The Dark Report.

Permanent PAMA Reform Must Happen in 2026 Read More »

PAMA Cuts Averted Until ‘27; Labs Plan Next Move

CEO SUMMARY: Clinical laboratories have again avoided a potential financial disaster, at least for now, after Congress shifted PAMA cuts to test reimbursement rates until January 2027. However, the victory is temporary absent permanent PAMA reform. To that end, laboratory leaders need to push lawmakers to pass the RESULTS Act, with one healthcare attorney suggesting

To access this post, you must purchase The Dark Report.

PAMA Cuts Averted Until ‘27; Labs Plan Next Move Read More »

Patient-Driven Testing Spurs New Opportunities

CEO SUMMARY: Patient-driven diagnostic testing is creating both opportunities and challenges for clinical laboratories, as increased demand and evolving business models stretch the industry’s capacity and profitability. However, an industry veteran in commercial lab products notes that the industry flexed with COVID-19 testing, and it can do so again if consumer-requested tests surge. Patients are

To access this post, you must purchase The Dark Report.

Patient-Driven Testing Spurs New Opportunities Read More »

Boosting Path Revenue with POC Services

CEO SUMMARY: The concept sounds simple—bring mobile point-of-care pathology services to physician offices and ambulatory surgical centers via specially equipped vehicles. Doctors Pathology Services explains some of the road bumps it hit along the way while also uncovering the benefits this approach brings to its client physicians. It’s an example of pathologists holding on to

To access this post, you must purchase The Dark Report.

Boosting Path Revenue with POC Services Read More »

;